BACKGROUND: Recent evidence indicates that CXC chemokines such as human interleukine-8 (IL-8) and rat cytokine-induced neutrophil chemoattractant (CINC) have mitogenic and anti-apoptotic functions in addition to their chemotactic activity toward neutrophils. In the liver, hepatocyte growth factor (HGF) is implicated as a mitogen in the regeneration of liver. However, little is known the interaction between HGF and CXC chemokines during liver injury, repair and regeneration. We hypothesized that HGF may stimulate the expression of such chemokines, which contributes to mitogenic action in liver regeneration. MATERIALS AND METHODS: Primary cultured rat hepatocytes were treated with recombinant human HGF (rhHGF), in the absence and presence of calpain inhibitor-1 (CI-1), genistein or anti-CINC-1 antibody. Levels of CINC-1 and its mRNA, tyrosine phosphorylation of HGF receptor (c-Met), the activation of transcription factor, nuclear factor-kappaB (NF-kappaB), and activities of DNA synthesis were measured. RESULTS: rhHGF enhanced the production of CINC-1 time- and dose-dependently, which followed the increased levels of CINC-1 mRNA. Under the same conditions, rhHGF increased the tyrosine phosphorylation of c-Met. The electrophoretic mobility shift assay revealed that rhHGF activated the nuclear translocation of NF-kappaB and its DNA binding. Proteasome inhibitor (CI-1) blocked the NF-kappaB activation and the CINC-1 production. The tyrosine kinase inhibitor (genistein) inhibited the activities of CINC-1 production and the DNA synthesis stimulated by rhHGF. However, the treatment of anti-CINC-1 antibody had no effect on the DNA synthesis. CONCLUSIONS: These results demonstrate that rhHGF can stimulate the induction of CINC-1 gene expression through the activation of NF-kappaB via its receptor c-Met in hepatocytes. Although CINC-1 seems to be not associated with the enhancement of DNA synthesis by rhHGF, it cannot negate the possibility that CINC-1 may contribute to liver repair and regeneration.
BACKGROUND: Recent evidence indicates that CXC chemokines such as human interleukine-8 (IL-8) and rat cytokine-induced neutrophil chemoattractant (CINC) have mitogenic and anti-apoptotic functions in addition to their chemotactic activity toward neutrophils. In the liver, hepatocyte growth factor (HGF) is implicated as a mitogen in the regeneration of liver. However, little is known the interaction between HGF and CXC chemokines during liver injury, repair and regeneration. We hypothesized that HGF may stimulate the expression of such chemokines, which contributes to mitogenic action in liver regeneration. MATERIALS AND METHODS: Primary cultured rat hepatocytes were treated with recombinant humanHGF (rhHGF), in the absence and presence of calpain inhibitor-1 (CI-1), genistein or anti-CINC-1 antibody. Levels of CINC-1 and its mRNA, tyrosine phosphorylation of HGF receptor (c-Met), the activation of transcription factor, nuclear factor-kappaB (NF-kappaB), and activities of DNA synthesis were measured. RESULTS: rhHGF enhanced the production of CINC-1 time- and dose-dependently, which followed the increased levels of CINC-1 mRNA. Under the same conditions, rhHGF increased the tyrosine phosphorylation of c-Met. The electrophoretic mobility shift assay revealed that rhHGF activated the nuclear translocation of NF-kappaB and its DNA binding. Proteasome inhibitor (CI-1) blocked the NF-kappaB activation and the CINC-1 production. The tyrosine kinase inhibitor (genistein) inhibited the activities of CINC-1 production and the DNA synthesis stimulated by rhHGF. However, the treatment of anti-CINC-1 antibody had no effect on the DNA synthesis. CONCLUSIONS: These results demonstrate that rhHGF can stimulate the induction of CINC-1 gene expression through the activation of NF-kappaB via its receptor c-Met in hepatocytes. Although CINC-1 seems to be not associated with the enhancement of DNA synthesis by rhHGF, it cannot negate the possibility that CINC-1 may contribute to liver repair and regeneration.
Authors: Laura P Stabile; Mary E Rothstein; Christopher T Gubish; Diana E Cunningham; Nathan Lee; Jill M Siegfried Journal: J Thorac Oncol Date: 2014-09 Impact factor: 15.609
Authors: Yoko Ito; Kelly Correll; Rachel L Zemans; Christina C Leslie; Robert C Murphy; Robert J Mason Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-04-10 Impact factor: 5.464